Larvol Delta - Efficacy-and-Safety-of-Ivarmacitinib-a-Highly-Selective-JAK1-Inhibitor-in-the-Treatment-of-ModeratetoSevere-Atopic-Dermatitis-in-Adults-A-Prospective-Multicenter-RealWorld-Observational-Study

AiSuDa (ivarmacitinib) - Jiangsu Hengrui Pharma, Arcutis

https://www.chictr.org.cn/showproj.html?proj=303113

Jul 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next